R.X. Lee is the Director at HighLight Capital. HighLight Capital is an investment firm managing $4.2 billion in assets, supported by leading endowments, foundations, and sovereign wealth funds across Asia, North America, Europe, and the Middle East. According to Preqin’s most recent global league table, HighLight Capital Fund II ranked among the top three best-performing funds worldwide for the 2016–2021 vintage. The firm has established a strong track record of successful investments in prominent healthcare，life sciences and AI companies.

Prior to joining the venture capital industry, Mr. Lee held positions in auditor at KPMG and EY, based in Shanghai. In these roles, he advised numerous Asian biopharmaceutical and medical device companies on initial public offerings and mergers and acquisitions.